79 results on '"Witte, T"'
Search Results
2. POS0096 SJÖGREN’S DISEASE AND SYSTEMIC LUPUS ERYTHEMATOSUS DDX6-CXCR5 RISK INTERVALS REVEAL COMMON SNPS WITH FUNCTIONAL SIGNIFICANCE IN IMMUNE AND SALIVARY GLAND CELLS
3. OP0111 INTEGRATION OF GWAS AND EPIGENETIC STUDIES IDENTIFIES NOVEL GENES THAT ALTER EXPRESSION IN THE MINOR SALIVARY GLAND IN SJÖGREN’S DISEASE
4. OP0098 PREDICTING TREATMENT OUTCOME IN PATIENTS WITH SPONDYLOARTHRITIS USING MICROBIOTA ANALYSIS
5. POS0789 CLINICAL FEATURES OF SJÖGREN’S SYNDROME WITH AND WITHOUT NEUROLOGICAL INVOLVEMENT (NEURO-SJÖGREN)
6. POS1483-HPR DYSFUNCTIONAL COPING CORRELATES WITH DEPRESSION AND ANXIETY AND PREDICTS WORSE OUTCOME IN PATIENTS WITH A HIGH DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS
7. AB0536 RELATIONSHIP OF EXERTIONAL ACTIVITY AND MENTAL WELLBEING IN SYSTEMIC LUPUS ERYTHEMATOSUS
8. POS0684 IS UPADACITINIB CAPABLE OF IMPROVING PATIENT-REPORTED OUTCOMES OF RHEUMATOID ARTHRITIS IN A REAL-WORLD SETTING? RESULTS FROM THE POST-MARKETING OBSERVATIONAL UPwArds STUDY
9. AB0255 BASELINE CHARACTERISTICS OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH UPADACITINIB IN GERMAN REAL-WORLD PRACTICE: RESULTS FROM THE POST-MARKETING OBSERVATIONAL UPwArds STUDY
10. OP0019 DEFINING SYSTEMIC LUPUS ERYTHEMATOSUS MOLECULAR TAXONOMY THROUGH DATA-DRIVEN RESTRATIFICATION AND IDENTIFICATION OF CLUSTER-TAILORED DRUGS FOR A PERSONALIZED MEDICINE APPROACH
11. OP0260-HPR PREDICTORS OF WORK PARTICIPATION IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AFTER 12 MONTHS OF T2T THERAPY INTERVENTION
12. AB0707 RHEUMATOLOGY PATIENT CARE IN THE COVID-19 PANDEMIC: TELEMEDICINE, DELEGATION, PATIENT SATISFACTION AND VACCINATION BEHAVIOUR
13. AB0322 ASSOCIATION OF DEPRESSIVE SYMPTOMS ASSESSED BY BDI II WITH PHYSICAL ACTIVITY IN PATIENTS WITH PRIMARY SJÖGREN´S SYNDROME
14. THU0263 LUNG INVOLVEMENT IN PRIMARY SJÖGREN SYNDROME – AN UNDER-DIAGNOSED ENTITY
15. OP0047 GENOME-WIDE ASSOCIATION STUDY OF SJÖGREN’S SYNDROME IDENTIFIES TEN NEW RISK LOCI
16. FRI0312 ANTI-CD74 IGA ANTIBODIES ARE MOST SENSITIVE AND SPECIFIC TO IDENTIFY YOUNG MALE AXIAL SPONDYLOARTHRITIS PATIENTS
17. AB1088 NAIL PSORIASIS: THE UNDERESTIMATED DISORDER IN PSORIASIS AND PSORIASIS ARTHRITIS. CAN ULTRASOUND AND CAPILLARY MICROSCOPY IN PATIENTS WITH NAIL PSORIASIS SPEED UP OUR DIAGNOSIS AND THERAPY?
18. OP0139 FUNCTIONAL EVALUATION OF THE SJÖGREN’S SYNDROME AND SYSTEMIC LUPUS ERYTHEMATOSUS DDX6-CXCR5 RISK INTERVAL
19. AB1298-HPR RHEUMA-VOR: A PROOF-OF-CONCEPT NETWORK STUDY FOR THE IMPROVEMENT OF RHEUMATOLOGICAL HEALTH CARE THROUGH COORDINATED COOPERATION
20. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility
21. THU0414 Inter SPA: Sensitivity and Specifity of Autoantibodies against CD74 in Early Axial Spondyloarthritis
22. OP0076 Autoantibodies against CD74 – A New Diagnostic Marker for Spondyloarthritis (SPA)
23. SAT0320 Igg3 Autoantibodies Binding To Stathmin-4 as Marker of Polyneuropathy in Primary Sjögren Syndrome
24. FRI0370 Two Subsets of Giant Cell Arteritis Characterized by The Absence or Presence of Spondyloarthritis or Its Associated Diseases
25. OP0081 Identification of a Sjögren's Syndrome-Associated Variant that Influences OAS1 Isoform Switching and Protein Expression
26. OP0127 Association of TYK2 with Systemic Sclerosis, A New Locus in the IL-12 Pathway
27. AB0150 Tocilizumab Does not Induce Apoptosis in Neutrophils in Vitro
28. THU0489 Antibodies Binding to DRP-4 and Macropain Subunit C2 as a Potential Marker of AOSD
29. THU0214 Treatment of refractory giant cell arteritis with cyclophosphamide. A retrospective analysis of 35 patients from three tertiary care centers
30. OP0020 Identification of Multiple Sjögren’s Syndrome Susceptibility Loci
31. FRI0350 Large vessel vasculitis and sacroiliitis: coincidence or associated diseases?
32. AB0898 Biomarker for spondyloarthritis: Autoantibodies against class II-associated invariant chain peptide (clip)
33. FRI0279 High prevalence of anti-CD 74 antibodies with specificity for the class II-associated invariant chain peptide (clip) in patients with axial spondyloarthritis but not in controls
34. OP0074 Clinical study: Frequency and manifestations of joint disease in HIV-infected patients
35. THU0224 Prevalence of antibodies against ferritin peptides: Epitope mapping of human ferritin heavy chain in GCA and PMR
36. AB0767 The association of ferritin autoantibodies with takayasu arteritis
37. AB0093 Association of cd247 polymorphisms with rheumatoid arthritis: a replication study and a meta-analysis
38. Autoantibodies against CD74 in spondyloarthritis
39. High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis: Table 1
40. Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica
41. Association of a non-synonymous functional variant of the ITGAM gene with systemic sclerosis
42. Successful clearance of hepatitis C virus with pegylated interferon -2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis
43. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis
44. Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers
45. Genetic association between methyl-CpG binding protein 2 (MECP2) and primary Sjogren's syndrome
46. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus
47. Treatment of lupus-prone NZB/NZW F1mice with recombinant soluble Fcγ receptor II (CD32)
48. Hypochlorhydria and hypergastrinaemia in rheumatoid arthritis.
49. Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort.
50. Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centres.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.